Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors
NCT02533674
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
57
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
Gemcitabine plus PM060184
Sponsor
PharmaMar